FAST
46
-2
STZ
54
-4
TDC
47
-2
PYPL
45
-2
NUE
50
3
JNJ
51
-2
LUV
36
7
BBY
59
7
AVY
54
-14
CHRW
48
8
NWL
32
-3
CMG
50
-6
SRE
54
-5
D
55
-6
BF.B
57
7
PWR
60
-2
LEG
29
4
ADP
70
-3
MS
50
-8
HUM
30
3
FAST
46
-2
STZ
54
-4
TDC
47
-2
PYPL
45
-2
NUE
50
3
JNJ
51
-2
LUV
36
7
BBY
59
7
AVY
54
-14
CHRW
48
8
NWL
32
-3
CMG
50
-6
SRE
54
-5
D
55
-6
BF.B
57
7
PWR
60
-2
LEG
29
4
ADP
70
-3
MS
50
-8
HUM
30
3
Financhill
Back

Hovnanian Enterprises Vs. Biomarin Pharmaceutical Industry Stock Comparison

Buy
63

HOV
Hovnanian Enterprises

Last Price:
223.19
Seasonality Move:
2.73%
Sell
33

BMRN
Biomarin Pharmaceutical

Last Price:
71.38
Seasonality Move:
5.7%
Buy
63
Hovnanian Enterprises (HOV) is a Buy

Is Hovnanian Enterprises a Buy, Sell or Hold?

  • The current Hovnanian Enterprises [HOV] share price is $223.46. The Score for HOV is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • HOV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Biomarin Pharmaceutical (BMRN) is a Sell

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $71.14. The Score for BMRN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HOV Stock Price Chart

What is Hovnanian Enterprises's stock price today?

  • The Hovnanian Enterprises share price today is $223.46
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HOV is experiencing slight selling pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $71.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

HOV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.54 Buy
Relative Strength Index (14 RSI): 63.3 Buy
Chaikin Money Flow: -26090 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (191.51 - 221.71) Buy
Bollinger Bands (100): (146.14 - 200.84) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 22.64 Sell
Chaikin Money Flow: 871265 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (80.02 - 93.28) Sell
Bollinger Bands (100): (78.57 - 88.29) Sell

HOV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 206.2 Buy
20-day SMA: 209.8 Buy
50-day SMA: 195.42 Buy
200-day SMA: 161.53 Buy
8-day EMA: 211.71 Buy
20-day EMA: 205.74 Buy
50-day EMA: 193.89 Buy
200-day EMA: 159.63 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 79.35 Sell
20-day SMA: 85.57 Sell
50-day SMA: 85.93 Sell
200-day SMA: 87.02 Sell
8-day EMA: 77.71 Sell
20-day EMA: 82.86 Sell
50-day EMA: 84.86 Sell
200-day EMA: 86.16 Sell

Hovnanian Enterprises Earnings Growth & HOV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.

Hovnanian Enterprises Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):